Pietro Lampertico
Pietro Lampertico
Professore di Gastroenterologia, UniversitÓ di Milano
Verified email at unimi.it
TitleCited byYear
EASL Clinical Practice Guidelines: management of chronic hepatitis B
European Association For The Study Of The Liver
J Hepatol 50, 227-242, 2009
17692009
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
European Association For The Study Of The Liver
Journal of hepatology 67 (2), 370-398, 2017
8182017
Adefovir dipivoxil therapy for lamivudine‐resistant hepatitis B in pre–and post–liver transplantation patients
ER Schiff, CL Lai, S Hadziyannis, P Neuhaus, N Terrault, M Colombo, ...
Hepatology 38 (6), 1419-1427, 2003
5332003
Low resistance to adefovir combined with lamivudine: a 3-year study of 145 lamivudine-resistant hepatitis B patients
P Lampertico, M Vigano, E Manenti, M Iavarone, E Sablon, M Colombo
Gastroenterology 133 (5), 1445-1451, 2007
4202007
Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell–mediated liver damage
C Dunn, M Brunetto, G Reynolds, T Christophides, PT Kennedy, ...
The Journal of Experimental Medicine 204 (3), 667-680, 2007
3862007
Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos (t) ide therapy: a systematic review
GV Papatheodoridis, P Lampertico, S Manolakopoulos, A Lok
Journal of hepatology 53 (2), 348-356, 2010
3822010
Adefovir rapidly suppresses hepatitis B in HBeAg‐negative patients developing genotypic resistance to lamivudine
P Lampertico, M Vigan˛, E Manenti, M Iavarone, G Lunghi, M Colombo
Hepatology 42 (6), 1414-1419, 2005
3592005
Clinical outcome of HBeAg‐negative chronic hepatitis B in relation to virological response to lamivudine
V Di Marco, A Marzano, P Lampertico, P Andreone, T Santantonio, ...
Hepatology 40 (4), 883-891, 2004
333*2004
Adefovir dipivoxil for wait‐listed and post–liver transplantation patients with lamivudine‐resistant hepatitis B: Final long‐term results
E Schiff, CL Lai, S Hadziyannis, P Neuhaus, N Terrault, M Colombo, ...
Liver transplantation 13 (3), 349-360, 2007
3122007
Long‐term suppression of hepatitis B e antigen‐negative chronic hepatitis B by 24‐month interferon therapy
P Lampertico, E Del Ninno, M Vigan˛, R Romeo, MF Donato, E Sablon, ...
Hepatology 37 (4), 756-763, 2003
2832003
A randomized, controlled trial of a 24‐month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum
P Lampertico, E Del Ninno, A Manzin, MF Donato, MG Rumi, G Lunghi, ...
Hepatology 26 (6), 1621-1625, 1997
2631997
Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection. A multicenter Italian study
GB Gaeta, G Stornaiuolo, DF Precone, S Lobello, M Chiaramonte, ...
Journal of hepatology 39 (6), 1036-1041, 2003
2442003
Prophylaxis and treatment of hepatitis B in immunocompromised patients
A Marzano, E Angelucci, P Andreone, M Brunetto, R Bruno, P Burra, ...
Digestive and Liver Disease 39 (5), 397-408, 2007
2422007
Restored Function of HBV-Specific T Cells after Long-Term Effective Therapy with Nucleos (t) ide Analogues
C Boni, D Laccabue, P Lampertico, T Giuberti, M Vigan˛, S Schivazappa, ...
Gastroenterology Jul 14. [Epub ahead of print], 2012
2182012
Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus–coinfected patients
G Raimondo, MR Brunetto, P Pontisso, A Smedile, AM Maina, C Saitta, ...
Hepatology 43 (1), 100-107, 2006
2092006
Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy
GV Papatheodoridis, HLY Chan, BE Hansen, HLA Janssen, P Lampertico
Journal of hepatology 62 (4), 956-967, 2015
2022015
Validation of a stopping rule at week 12 using HBsAg and HBV DNA for HBeAg-negative patients treated with peginterferon alfa-2a
V Rijckborst, BE Hansen, P Ferenci, MR Brunetto, F Tabak, Y Cakaloglu, ...
Journal of Hepatology 56 (5), 1006-11, 2012
1802012
Entecavir plus tenofovir combination as rescue therapy in pretreated chronic hepatitis B patients. An international multicenter cohort study
J Petersen, V Ratziu, M Buti, HLA Janssen, A Brown, P Lampertico, ...
Journal of Hepatology 56 (3), 520-526, 2011
1412011
IL28B polymorphisms predict interferon‐related hepatitis B surface antigen seroclearance in genotype D hepatitis B e antigen–negative patients with chronic hepatitis B
P Lampertico, M Vigan˛, C Cheroni, F Facchetti, F Invernizzi, V Valveri, ...
Hepatology 57 (3), 890-896, 2013
1382013
High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity
MF Donato, E Arosio, E Del Ninno, G Ronchi, P Lampertico, A Morabito, ...
Hepatology 34 (3), 523-528, 2001
1342001
The system can't perform the operation now. Try again later.
Articles 1–20